Rabeprazole Sodium

Specifications

117976-90-6CAS Number

629-730-3EC Number

sodium 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]benzimidazol-1-ideIUPAC Name

C18H20N3NaO3SChemical Formula

381.4 g/molMolecular Weight

RABEPRAZOLE SODIUM; 117976-90-6; Rabeprazole sodium salt; Rabeprazole na; Sodium rabeprazole; LY307640 sodium; Idiazole; Aciphex Sprinkle; LY 307640 sodium; DTXSID3044205; E-3810 SODIUM; LY-307640 SODIUM; 3L36P16U4R; NSC-759270; CHEBI:8769; DTXCID1024205; 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt; 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridyl)methyl)sulfinyl)benzimidazole sodium salt; Rablet; 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfinyl]benzimidazole sodium salt; Sodium, Rabeprazole; Rabeprazole Sodium DR; RefChem:57365; RABERPRAZOLE SODIUM D/R; rabeprazole sodium delayed-release; Rebeprazole sodium; Pariet; Aciphex; (S)-Rabeprazole Sodium Salt; Rabeprazole sodium [USAN]; Rabeprazole (sodium); 171440-19-0; sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide; C18H20N3NaO3S; MFCD02092688; Sodium 2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide; Rabicip; Pepcia; sodium 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)benzimidazol-1-ide; SMR000550493; CAS-117976-90-6; NCGC00159518-02; pariete; UNII-3L36P16U4R; Aciphex Sodium; Pariprazole sodium; Habeprazole Sodium; E 3810; Dexrabeprazolesodium; Aciphex (TN); Pariet (TN); MLS001165734; MLS006010621; Rabeprazole Sodium Impurity W; SCHEMBL140494; RABEPRAZOLE NA [VANDF]; HY-B0656AR; orb1226867; CHEMBL1200930; RABEPRAZOLE SODIUM [JAN]; SCHEMBL29389773; SCHEMBL29632545; HY-B0656A; Rabeprazole (sodium) (Standard); Rabeprazole sodium (JP17/USP); EX-A176; GLXC-05474; HMS2093H10; HMS2231E04; HMS3373B05; HMS5083C12; RABEPRAZOLE SODIUM [MART.]; RABEPRAZOLE SODIUM [USP-RS]; RABEPRAZOLE SODIUM [WHO-DD]; Sodium (S)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide; Tox21_111736; Tox21_302317; AC-715; EBC-84232; RABEPRAZOLE SODIUM SALT [MI]; s4665; Rabeprazole sodium, >=98% (HPLC); AKOS015895734; AKOS015962116; AKOS025310160; Rabeprazole for system suitability CRS; Tox21_111736_1; CCG-213574; CCG-268423; IM57865; NSC 759270; RABEPRAZOLE SODIUM [ORANGE BOOK]; NCGC00159518-05; NCGC00255838-01; RABEPRAZOLE SODIUM [EP MONOGRAPH]; 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1); AS-13338; BR167318; RABEPRAZOLE SODIUM [USP MONOGRAPH]; Rabeprazole sodium salt - Bio-X trade mark; R0115; C07865; D00724; F17418; F224581; SR-01000799133; SR-01000799133-2; Q27108142; [2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-yl]sodium; sodium 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)benzo[d]imidazol-1-ide; sodium 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]benzimidazol-1-ide; Sodium 2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2-yl]methylsulfinyl]benzoimidazole; sodium;2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-ide; sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole; 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole sodium salt; Sodium 2-{[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanesulfinyl}-1,3-benzimidazol-1-ideSynonyms